Michael Egan
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment
- Dementia and Cognitive Impairment Research
Papers in ⓘ
-
- Schizophrenia research and treatment 8
- Dementia and Cognitive Impairment Research 4
- Bipolar Disorder and Treatment 3
-
- Cholinesterase and Neurodegenerative Diseases 6
- Co-authors
- Terry E. Goldberg (6 shared papers)Tiffini Voss (10 shared papers)Yuki Mukai (7 shared papers)James Kost (9 shared papers)Christine Furtek (8 shared papers)Jeffrey L. Cummings (6 shared papers)Bruno Vellas (5 shared papers)Pierre N. Tariot (5 shared papers)
- Journals
- Alzheimer s & Dementia (5 papers)Biological Psychiatry (5 papers)Schizophrenia Research (4 papers)American Journal of Psychiatry (3 papers)New England Journal of Medicine (3 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Michael Egan
37 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Biological Psychiatry 197
- Psychiatry and Mental health 580
- Physiology 795
- Pharmacology 455
- Cellular and Molecular Neuroscience 394
Countries citing papers authored by Michael Egan
This map shows the geographic impact of Michael Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Egan more than expected).
Fields of papers citing papers by Michael Egan
This network shows the impact of papers produced by Michael Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Egan. The network helps show where Michael Egan may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease Hit paper breakdown → | 2018 | 471 |
| 2 | Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease Hit paper breakdown → | 2019 | 380 |
| 3 | 1999 | 271 | |
| 4 | 2000 | 137 | |
| 5 | 2003 | 75 | |
| 6 | 1980 | 64 | |
| 7 | 2019 | 63 | |
| 8 | 2020 | 59 | |
| 9 | 2008 | 58 | |
| 10 | 1985 | 54 | |
| 11 | 1994 | 52 | |
| 12 | 2018 | 45 | |
| 13 | 2013 | 42 | |
| 14 | 2010 | 33 | |
| 15 | 2012 | 20 | |
| 16 | 2024 | 10 | |
| 17 | 1993 | 8 | |
| 18 | 2020 | 8 | |
| 19 | 2000 | 8 | |
| 20 | 2022 | 7 |
About Michael Egan
Michael Egan is a scholar working on Psychiatry and Mental health, Pharmacology, Biological Psychiatry, Metals and Alloys and Physiology, having authored 40 papers that have together received 1.9k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (8 papers), Alzheimer's disease research and treatments (6 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Dementia and Cognitive Impairment Research (4 papers), Phosphodiesterase function and regulation (3 papers), Bipolar Disorder and Treatment (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Biological Psychiatry (197 citations), Psychiatry and Mental health (580 citations), Physiology (795 citations), Pharmacology (455 citations) and Cellular and Molecular Neuroscience (394 citations). Michael Egan has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Terry E. Goldberg, Tiffini Voss, Yuki Mukai, James Kost, Christine Furtek, Jeffrey L. Cummings, Bruno Vellas, Pierre N. Tariot, Paul Aisen and Erin Mahoney. Their work appears in journals such as Alzheimer s & Dementia, Biological Psychiatry, Schizophrenia Research, American Journal of Psychiatry and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.